Chris Edwards
- The effect of amoxicillin in lower respiratory tract infection (LRTI): A placebo controlled RCT in 16 primary care GRACE networks from 12 countries in EuropeBy Paul Little, Beth Stuart, Theo Verheij, Chris Butler, Michael Moore, Samuel Coenen, Maciek Godycki-Cwirko, Artur Mierzecki, Slawomir Shlabicz, Antoni Torres, Jordi Almirall, Peter Edwards, Tom Schaberg, Sigvard Mölstad, Francesco Blasi, An De Sutter, Janko Kersnik, Helena Hupkova, Pia Touboul, Mark Mullee and Herman GoossensPaul Little1Primary Care Medical Group, University of Southampton Medical School, Southampton, United KingdomBeth Stuart1Primary Care Medical Group, University of Southampton Medical School, Southampton, United KingdomTheo Verheij3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, NetherlandsChris Butler4Department of General Practice, Cardiff University, Cardiff, United KingdomMichael Moore1Primary Care Medical Group, University of Southampton Medical School, Southampton, United KingdomSamuel Coenen5Department of General Practice, University of Antwerp, Antwerp, BelgiumMaciek Godycki-Cwirko6Department of Family and Community Medicine, Medical University of Lodz, Lodz, PolandArtur Mierzecki7Independent Laboratory of Family Physician Education, Pomeranian Medical University, Szczecin, PolandSlawomir Shlabicz8Department of Family Medicine and Community Nursing, Medical University of Bialystok, Bialystok, PolandAntoni Torres9Servei de Pneumologia, Institut Clinic del Torax, Barcelona, SpainJordi Almirall10Intensive Care Unit, Hospital de Mataro, Mataro, SpainPeter Edwards11Ely Bridge Surgery, Ely Bridge Surgery, Cardiff, United KingdomTom Schaberg12Zentrum für Pheumologie, Diakoniekrankenhaus Rotenburg, Rotenburg, GermanySigvard Mölstad13Unit of Research and Development in Primary Health Care, Jonkoping, Jonkoping, SwedenFrancesco Blasi14Istituto Malattie Respiratorie, University of Milan, Milan, ItalyAn De Sutter15Ghent University, University Hospital, Ghent, BelgiumJanko Kersnik16Zdravstveni dom Jesenice, Zdravstveni dom Jesenice, Jesenice, SloveniaHelena Hupkova17Faculty of Pharmacy, Comenius University Bratislava, Bratislava, Slovakia (Slovak Republic)Pia Touboul18Département de Santé Publique, Hôpital de l' Archet 1, Nice, FranceMark Mullee1Primary Care Medical Group, University of Southampton Medical School, Southampton, United KingdomHerman Goossens2Laboratory of Medical Microbiology, University of Antwerp, Antwerp, Belgium
- Preclinical evaluation of GSK2245035, a potent and selective toll-like receptor 7 (TLR7) agonistBy Diana Quint, Jo Hessey, Diane Coe, Fiona Priest, Aimee Hillegas, Deidre Dalmas Wilk, Mark Price, Chris Edwards and Keith BiggadikeDiana Quint1Respiratory Therapeutic Area, GSK, Stevenage, United KingdomJo Hessey1Respiratory Therapeutic Area, GSK, Stevenage, United KingdomDiane Coe1Respiratory Therapeutic Area, GSK, Stevenage, United KingdomFiona Priest1Respiratory Therapeutic Area, GSK, Stevenage, United KingdomAimee Hillegas2Safety Assessment, GSK, Upper Merion,Deidre Dalmas Wilk2Safety Assessment, GSK, Upper Merion,Mark Price3Safety Assessment, GSK, Ware, United KingdomChris Edwards1Respiratory Therapeutic Area, GSK, Stevenage, United KingdomKeith Biggadike1Respiratory Therapeutic Area, GSK, Stevenage, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.